USMLE Forums banner
1 - 6 of 6 Posts

·
Registered
Joined
·
238 Posts
Discussion Starter · #1 ·
40y/o woman, discomfort in RUQ after eating. USS shows small cholesterol gallstones. She begins oral therapy with ursodeoxycholic acid. Which of the following is the best rationale for this treatment?

A) Addition of bilirubin to bile
B) Decreased concentration of bile acids
C) Decreased ratio of cholesterol to bile acids
D) Increased in the ability of the gallbladder to concentrate bile
E) increased in the concentration of lecithin in bile

Which is the answer, and why?:confused:
 

·
Registered
Joined
·
236 Posts
The correct answer is D. Ursodeoxycholic acid is an option of treatment for cholesterol stones, with high failure and recurrence rate. Its main action is to "dissolve cholesterol stones" by increasing the concentration level of cholesterol at which saturation of bile with the latter occurs. In another wards it increases the ability of bile to dissolve cholesterol. If for example cholesterol precipitates on 100mg/dl, with ursodeoyxcholesterol it precipitates in 150mg/dl. Those numbers are just for clarification. It's also used in PBC and decreases disease progression, a commonly asked point in CK.

Ofcourse this choice and C are the only reasonable ones, other changes listed do not affect stone formtion or increase it.
 

·
Registered
Joined
·
586 Posts
I was thinking that bile acid sequestrants block the reabsorption of bile acids from the gut and thereby interrupting the enterohepatic circulation.
Therefore, the liver cell will direct it's cholestrol synthesis toward bile acids instead of acumilating in the lipoproteins and increased cellular synthesis also increases LDL receptor uptake.
Therefore choice C is the correct answer.

this is just my thinking may be drseddik is correct
 

·
Registered
Joined
·
236 Posts
I was thinking that bile acid sequestrants block the reabsorption of bile acids from the gut and thereby interrupting the enterohepatic circulation.
Therefore, the liver cell will direct it's cholestrol synthesis toward bile acids instead of acumilating in the lipoproteins and increased cellular synthesis also increases LDL receptor uptake.
Therefore choice C is the correct answer.

this is just my thinking may be drseddik is correct
You are correct, but this is the mechanism of formation of gall stones (not treatment) in those taking bile acid sequestrants (also in crohn's disease), due to high (not low as the question says) cholesterol/bile acids. Ursodeoxycholic acid is not a bile acid sequestrant, it's a hydrophilic bile acid, it works by diffirent complicated mechanisms but the net effect is solubilization of stones (instead of cholecystectomy), not used for hyperlipidemias.
 

·
Registered
Joined
·
586 Posts
You are correct, but this is the mechanism of formation of gall stones (not treatment) in those taking bile acid sequestrants (also in crohn's disease), due to high (not low as the question says) cholesterol/bile acids. Ursodeoxycholic acid is not a bile acid sequestrant, it's a hydrophilic bile acid, it works by diffirent complicated mechanisms but the net effect is solubilization of stones (instead of cholecystectomy), not used for hyperlipidemias.
You are a star
 
1 - 6 of 6 Posts
This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Top